Literature DB >> 15681025

Why does the rapid delivery of drugs to the brain promote addiction?

Anne-Noël Samaha1, Terry E Robinson.   

Abstract

It is widely accepted that the more rapidly drugs of abuse reach the brain the greater their potential for addiction. This might be one reason why cocaine and nicotine are more addictive when they are smoked than when they are administered by other routes. Traditionally, rapidly administered drugs are thought to be more addictive because they are more euphorigenic and/or more reinforcing. However, evidence for this is not compelling. We propose an alternative (although not mutually exclusive) explanation based on the idea that the transition to addiction involves drug-induced plasticity in mesocorticolimbic systems, changes that are manifested behaviourally as psychomotor and incentive sensitization. Recent evidence suggests that rapidly administered cocaine or nicotine preferentially engage mesocorticolimbic circuits, and more readily induce psychomotor sensitization. We conclude that rapidly delivered drugs might promote addiction by promoting forms of neurobehavioural plasticity that contribute to the compulsive pursuit of drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681025     DOI: 10.1016/j.tips.2004.12.007

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  87 in total

1.  Episodic withdrawal promotes psychomotor sensitization to morphine.

Authors:  Patrick E Rothwell; Jonathan C Gewirtz; Mark J Thomas
Journal:  Neuropsychopharmacology       Date:  2010-09-01       Impact factor: 7.853

2.  Smoking produces rapid rise of [11C]nicotine in human brain.

Authors:  Marc S Berridge; Scott M Apana; Kenichi K Nagano; Catherine E Berridge; Gregory P Leisure; Mark V Boswell
Journal:  Psychopharmacology (Berl)       Date:  2010-03-16       Impact factor: 4.530

Review 3.  A qualitative and quantitative review of cocaine-induced craving: the phenomenon of priming.

Authors:  James J Mahoney; Ari D Kalechstein; Richard De La Garza; Thomas F Newton
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-01-31       Impact factor: 5.067

4.  Caffeine Induces a Stimulant Effect and Increases Dopamine Release in the Nucleus Accumbens Shell Through the Pulmonary Inhalation Route of Administration in Rats.

Authors:  Martín Galvalisi; José Pedro Prieto; Marcela Martínez; Juan Andrés Abin-Carriquiry; Cecilia Scorza
Journal:  Neurotox Res       Date:  2016-09-08       Impact factor: 3.911

5.  Intermittent intake of rapid cocaine injections promotes the risk of relapse and increases mesocorticolimbic BDNF levels during abstinence.

Authors:  Aliou B Gueye; Florence Allain; Anne-Noël Samaha
Journal:  Neuropsychopharmacology       Date:  2018-10-26       Impact factor: 7.853

6.  The rate of intravenous cocaine administration alters c-fos mRNA expression and the temporal dynamics of dopamine, but not glutamate, overflow in the striatum.

Authors:  C R Ferrario; M Shou; A N Samaha; C J Watson; R T Kennedy; T E Robinson
Journal:  Brain Res       Date:  2008-03-07       Impact factor: 3.252

Review 7.  Modeling cocaine relapse in rodents: Behavioral considerations and circuit mechanisms.

Authors:  Mitchell R Farrell; Hannah Schoch; Stephen V Mahler
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-01-03       Impact factor: 5.067

8.  Varying the rate of intravenous cocaine infusion influences the temporal dynamics of both drug and dopamine concentrations in the striatum.

Authors:  Ellie-Anna Minogianis; Waqqas M Shams; Omar S Mabrouk; Jenny-Marie T Wong; Wayne G Brake; Robert T Kennedy; Patrick du Souich; Anne-Noël Samaha
Journal:  Eur J Neurosci       Date:  2018-07-24       Impact factor: 3.386

Review 9.  Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse.

Authors:  F Ivy Carroll; James L Howard; Leonard L Howell; Barbara S Fox; Michael J Kuhar
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

10.  Bioavailability of (+)-methamphetamine in the pigeon following an intramuscular dose.

Authors:  Howard P Hendrickson; William C Hardwick; D E McMillan; S Michael Owens
Journal:  Pharmacol Biochem Behav       Date:  2008-03-29       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.